RecruitingNCT02815891
A Longitudinal Observational Study of Patients With Nonalcoholic Steatohepatitis (NASH) and Related Conditions Across the Entire Spectrum of Nonalcoholic Fatty Liver Disease (NAFLD)
Sponsor
Target PharmaSolutions, Inc.
Enrollment
15,000 participants
Start Date
Jul 1, 2016
Study Type
OBSERVATIONAL
Conditions
Summary
TARGET-NASH is a longitudinal observational cohort study of patients being managed for NASH and related conditions across the entire spectrum NAFLD in usual clinical practice. TARGET-NASH is a research registry of patients with NAFL or NASH within academic and community real-world practices maintained in order to assess the safety and effectiveness of current and future therapies.
Eligibility
Min Age: 2 Years
Inclusion Criteria1
- \. Adults and children (age 2 or older) being managed or treated for nonalcoholic fatty liver disease. Diagnosis is based on the clinical judgement of the care provider.
Exclusion Criteria1
- \. Inability to provide informed assent/consent.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(74)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT02815891
Related Trials
Predicting Outcomes in Nonalcoholic Steatohepatitis With Advanced Fibrosis
NCT057206632 locations
Thyroid Hormone for Treatment of Nonalcoholic Steatohepatitis in Veterans
NCT055261441 location
Effect of a GnRH Analog on Hepatic Steatosis
NCT065235302 locations
Screening and Follow-up in Patients With HIV Infection Combined With Metabolic Associated Fatty Liver Disease
NCT053309231 location
Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity
NCT063357711 location